Bangladesh documents

Annual progress reports

Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.

Annual progress report Bangladesh 2006

Annual progress report Bangladesh 2014

Annual progress report Bangladesh 2005

Annual progress report Bangladesh 2013

Annual progress report Bangladesh 2004

Annual progress report Bangladesh 2012

Annual progress report Bangladesh 2003

Annual progress report Bangladesh 2010

Annual progress report Bangladesh 2002

Annual progress report Bangladesh 2009

Annual progress report Bangladesh 2008

Annual progress report Bangladesh 2007

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Multi-stakeholder dialogue Bangladesh 2020

Joint Appraisal Bangladesh 2019

Joint Appraisal Bangladesh 2016

Joint Appraisal Bangladesh 2015

Joint Appraisal Bangladesh 2014

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for TCA support 2022:Bangladesh

Date of Gavi approval:

Proposal for CCEOP support (2019-2022) :Bangladesh

Date of Gavi approval:

Proposal for HSS support (2016-2018) :Bangladesh

Date of Gavi approval:

Proposal for NVS - MR follow-up support 2019 - Bangladesh

Date of Gavi approval:

Proposal for NVS - rota support: Bangladesh 2017

Date of Gavi approval:

Proposal for HSS support 2016: Bangladesh

Date of Gavi approval:

Proposal for NVS - HPV Demo: Bangladesh

Date of Gavi approval:

Proposal for NVS – IPV support

Date of Gavi approval:

Proposal for NVS - MR 2013: Bangladesh

Date of Gavi approval:

Proposal for NVS - MR campaign support: Bangladesh

Date of Gavi approval:

Proposal for NVS - PCV support: Bangladesh

Date of Gavi approval:

Proposal for NVS - MSD support: Bangladesh

Date of Gavi approval:

Proposal for ISS support: Bangladesh

Date of Gavi approval:

Proposal for HSS support: Bangladesh

Date of Gavi approval:

Proposal for NVS - Penta support: Bangladesh

Date of Gavi approval:

Proposal for INS support: Bangladesh

Date of Gavi approval:

Proposal for ISS, NVS - Hep B support: Bangladesh

Date of Gavi approval:

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive Multi-Year Plan Bangladesh 2018-2022

Comprehensive multi-year plan for 2011-2016

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Bangladesh

Data quality audit

The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more. 

DQA 2003

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision Letter IPV FER Bangladesh 2023

Decision Letter PENTA FER Bangladesh 2023

Decision Letter Measles Bangladesh 2023

Decision Letter PCV FER Bangladesh 2023

Decision Letter PENTA Bangladesh 2023

Decision Letter PCV Bangladesh 2023

Decision Letter IPV FER Bangladesh 2022

Decision Letter IPV Bangladesh 2022

Decision Letter PCV Bangladesh 2022

Decision Letter PENTA Bangladesh 2022

Decision Letter MR Bangladesh 2022

Decision Letter PCV FER Bangladesh 2022

Decision Letter PENTA FER Bangladesh 2022

Decision Letter IPV Bangladesh 2021

Decision Letter MR Bangladesh 2021

Decision Letter PCV Bangladesh 2021

Decision Letter PENTA Bangladesh 2021

Decision Letter HSS Bangladesh 2021

Decision Letter PCV Bangladesh 2020

Decision Letter IPV Bangladesh 2020

Decision Letter PENTA Bangladesh 2020

Decision Letter MR Bangladesh 2020

Decision Letter HSS Bangladesh 2020

Decision Letter ISD Bangladesh 2020

Decision Letter IPV Bangladesh 2019

Decision Letter PENTA Bangladesh 2019

Decision Letter MR Bangladesh 2019

Decision Letter PCV Bangladesh 2019

Decision Letter HSS Bangladesh 2019

Decision Letter NVS Bangladesh 2017 (4)

Decision Letter Devices Bangladesh 2017

Decision Letter NVS Bangladesh 2016

Decision Letter HSS Bangladesh 2014

Bangladesh Decision Letter MR campaign 2019

Decision Letter NVS Bangladesh 2017 (5)

Decision Letter NVS Bangladesh 2017

Decision letter NVS Bangladesh 2015 (3)

Decision letter NVS Bangladesh 2013(2)

Bangladesh Decision Letter HSS 2019

Decision Letter NVS Bangladesh 2017 (6)

Decision Letter Devices Bangladesh 2016 (2)

Decision letter NVS Bangladesh 2015 (2)

Decision letter HSS Bangladesh 2013

Decision Letter Bangladesh Measles-Rubella 2019

Decision Letter NVS Bangladesh 2017 (7)

Decision Letter NVS Bangladesh 2016 (4)

Decision Letter NVS Bangladesh 2015

Decision letter NVS Bangladesh 2013

Decision Letter HSS Bangladesh 2018

Decision Letter Operational costs Bangladesh 2017

Decision Letter Devices Bangladesh 2016

Decision Letter NVS Bangladesh 2014(3)

Partnership Framework Agreement Bangladesh

Decision Letter NVS Bangladesh 2018

Decision Letter Devices Bangladesh 2017 (2)

Decision Letter NVS Bangladesh 2016 (2)

Decision Letter NVS Bangladesh 2014

Decision Letter Devices Bangladesh 2017 (3)

Decision Letter NVS Bangladesh 2017 (3)

Decision Letter NVS Bangladesh 2016 (3)

Decision Letter NVS Bangladesh 2014(2)

Decision Letter Devices Bangladesh 2017 (4)

Decision Letter NVS Bangladesh 2017 (2)

Decision Letter HSS Bangladesh 2016

Decision letter NVS Bangladesh 2014 (4)

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Bangladesh 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Bangladesh 2022

Targeted Country Assistance Plan Bangladesh 2021

Targeted Country Assistance Plan Bangladesh 2020

Targeted Country Assistance Plan Bangladesh 2019

Targeted country assistance plan Bangladesh 2018

Targeted country assistance plan Bangladesh 2017

Subscribe to our newsletter